CellaVision AB (publ)
CellaVision AB (publ) Fundamental Analysis
CellaVision AB (publ) (CLVSF) shows moderate financial fundamentals with a PE ratio of 22.28, profit margin of 20.17%, and ROE of 18.01%. The company generates $0.8B in annual revenue with moderate year-over-year growth of 6.78%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 76.7/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze CLVSF's fundamental strength across five key dimensions:
Efficiency Score
ExcellentCLVSF demonstrates superior asset utilization.
Valuation Score
ModerateCLVSF shows balanced valuation metrics.
Growth Score
ModerateCLVSF shows steady but slowing expansion.
Financial Health Score
ExcellentCLVSF maintains a strong and stable balance sheet.
Profitability Score
ExcellentCLVSF achieves industry-leading margins.
Key Financial Metrics
Is CLVSF Expensive or Cheap?
P/E Ratio
CLVSF trades at 22.28 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, CLVSF's PEG of 2.24 indicates potential overvaluation.
Price to Book
The market values CellaVision AB (publ) at 3.84 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 17.43 times EBITDA. This signals the market has high growth expectations.
How Well Does CLVSF Make Money?
Net Profit Margin
For every $100 in sales, CellaVision AB (publ) keeps $20.17 as profit after all expenses.
Operating Margin
Core operations generate 26.62 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.01 in profit for every $100 of shareholder equity.
ROA
CellaVision AB (publ) generates $13.98 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
CellaVision AB (publ) generates strong operating cash flow of $200.53M, reflecting robust business health.
Free Cash Flow
CellaVision AB (publ) generates strong free cash flow of $114.26M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $4.79 in free cash annually.
FCF Yield
CLVSF converts 3.35% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
22.28
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
2.24
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.84
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.49
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.03
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.98
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.18
vs 25 benchmark
ROA
Return on assets percentage
0.14
vs 25 benchmark
ROCE
Return on capital employed
0.21
vs 25 benchmark
How CLVSF Stacks Against Its Sector Peers
| Metric | CLVSF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 22.28 | 29.45 | Better (Cheaper) |
| ROE | 18.01% | 779.00% | Weak |
| Net Margin | 20.17% | -24930.00% (disorted) | Strong |
| Debt/Equity | 0.03 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 3.98 | 4.65 | Strong Liquidity |
| ROA | 13.98% | -19333.00% (disorted) | Strong |
CLVSF outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews CellaVision AB (publ)'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
56.62%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
41.90%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
57.50%
Industry Style: Defensive, Growth, Innovation
High Growth